Scinai Immunotherapeutics (SCNI) Competitors $3.02 +0.09 (+3.07%) (As of 02:30 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends SCNI vs. KLTO, ONVO, APTO, CELZ, BCDA, FRTX, SLXN, GENE, GRTS, and TTNPShould you be buying Scinai Immunotherapeutics stock or one of its competitors? The main competitors of Scinai Immunotherapeutics include Klotho Neurosciences (KLTO), Organovo (ONVO), Aptose Biosciences (APTO), Creative Medical Technology (CELZ), BioCardia (BCDA), Fresh Tracks Therapeutics (FRTX), Silexion Therapeutics (SLXN), Genetic Technologies (GENE), Gritstone bio (GRTS), and Titan Pharmaceuticals (TTNP). These companies are all part of the "biological products, except diagnostic" industry. Scinai Immunotherapeutics vs. Klotho Neurosciences Organovo Aptose Biosciences Creative Medical Technology BioCardia Fresh Tracks Therapeutics Silexion Therapeutics Genetic Technologies Gritstone bio Titan Pharmaceuticals Scinai Immunotherapeutics (NASDAQ:SCNI) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends. Does the media prefer SCNI or KLTO? In the previous week, Scinai Immunotherapeutics' average media sentiment score of 0.00 equaled Klotho Neurosciences'average media sentiment score. Company Overall Sentiment Scinai Immunotherapeutics Neutral Klotho Neurosciences Neutral Does the MarketBeat Community prefer SCNI or KLTO? Scinai Immunotherapeutics and Klotho Neurosciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformScinai ImmunotherapeuticsN/AN/AKlotho NeurosciencesN/AN/A Which has stronger valuation and earnings, SCNI or KLTO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScinai ImmunotherapeuticsN/AN/A-$6.50M-$254.17-0.01Klotho NeurosciencesN/AN/A$1.35MN/AN/A Is SCNI or KLTO more profitable? Scinai Immunotherapeutics' return on equity of 0.00% beat Klotho Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets Scinai ImmunotherapeuticsN/A N/A -107.47% Klotho Neurosciences N/A -1.48%-23.63% Do insiders and institutionals hold more shares of SCNI or KLTO? 58.4% of Scinai Immunotherapeutics shares are held by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are held by institutional investors. 60.9% of Scinai Immunotherapeutics shares are held by insiders. Comparatively, 2.0% of Klotho Neurosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryScinai Immunotherapeutics beats Klotho Neurosciences on 3 of the 5 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get Scinai Immunotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCNI vs. The Competition Export to ExcelMetricScinai ImmunotherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.75M$2.98B$5.10B$8.84BDividend YieldN/A1.91%5.04%4.07%P/E Ratio-0.0119.4095.1214.22Price / SalesN/A286.461,217.3088.42Price / CashN/A169.3839.4936.27Price / Book-0.314.486.976.37Net Income-$6.50M-$41.63M$118.73M$225.56M7 Day Performance1.34%-3.93%-1.22%-0.02%1 Month Performance-21.56%-5.61%-3.07%2.04%1 Year Performance-49.66%27.32%32.52%28.00% Scinai Immunotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCNIScinai Immunotherapeutics0.8463 of 5 stars$3.02+3.1%N/A-50.3%$1.75MN/A-0.0131KLTOKlotho NeurosciencesN/A$0.33-2.5%N/AN/A$5.72MN/A0.00N/AONVOOrganovo0.6793 of 5 stars$0.32-8.2%N/A-72.7%$4.94M$110,000.00-0.3320Analyst ForecastNews CoverageAPTOAptose Biosciences1.9977 of 5 stars$0.26-6.6%$4.33+1,599.3%-90.0%$4.62MN/A-0.0931Analyst ForecastNews CoverageGap UpCELZCreative Medical Technology1.7302 of 5 stars$2.63+3.1%N/A-41.6%$4.60M$10,000.00-0.675Analyst RevisionPositive NewsBCDABioCardia3.0668 of 5 stars$2.11+6.0%$25.00+1,084.8%-81.6%$4.47M$480,000.00-0.4916Analyst RevisionGap UpFRTXFresh Tracks TherapeuticsN/A$0.72flatN/A-9.5%$4.27M$8.01M0.0020SLXNSilexion TherapeuticsN/A$0.30-10.4%$1.00+235.1%N/A$4.13MN/A0.00N/ANews CoverageGap DownGENEGenetic Technologies0.2144 of 5 stars$0.77flatN/AN/A$3.71M$5.03M0.0050High Trading VolumeGRTSGritstone bio1.1515 of 5 starsN/A$2.17+∞N/A$3.50M$496,000.00-0.03190News CoverageGap DownHigh Trading VolumeTTNPTitan Pharmaceuticals0.7981 of 5 stars$3.80+4.1%N/A-49.2%$3.46M$180,000.000.0010News Coverage Related Companies and Tools Related Companies Klotho Neurosciences Alternatives Organovo Alternatives Aptose Biosciences Alternatives Creative Medical Technology Alternatives BioCardia Alternatives Fresh Tracks Therapeutics Alternatives Silexion Therapeutics Alternatives Genetic Technologies Alternatives Gritstone bio Alternatives Titan Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCNI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scinai Immunotherapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scinai Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
